Abdera Therapeutics Funding: $142M Raised, Series B (2023)
Abdera Therapeutics is based in Vancouver, Canada. It has raised $142M in total funding. Latest round: Series B.
Abdera Therapeutics funding overview
Abdera Therapeutics is based in Vancouver, Canada. Abdera Therapeutics has raised $142M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in April 2023. The round record for Abdera Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Versant Ventures, AbCellera, adMare BioInnovations, Foresite Capital, venBio. 5 distinct backers are named across the disclosed rounds.
Frequently asked about Abdera Therapeutics funding
How much has Abdera Therapeutics raised?
Abdera Therapeutics has raised $142M in total disclosed funding across the rounds on record.
Who has invested in Abdera Therapeutics?
Versant Ventures, AbCellera, adMare BioInnovations, Foresite Capital, venBio are named among the investors backing Abdera Therapeutics.
What was the latest Abdera Therapeutics funding round?
The most recent disclosed round is a Series B, announced in April 2023.
Where is Abdera Therapeutics based?
Abdera Therapeutics is based in Vancouver, Canada.
When did Abdera Therapeutics last raise?
The last disclosed Abdera Therapeutics round closed in April 2023 at Series B.
We update the Abdera Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Vancouver and their backers are listed below.
